Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DAVA
DAVA logo

DAVA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Endava PLC (DAVA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.420
1 Day change
52 Week Range
21.810
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Endava PLC (DAVA) is not a strong buy at the moment due to weak financial performance, bearish technical indicators, and lack of significant positive catalysts. For a beginner investor with a long-term focus, it is better to hold off on investing in this stock until there are clearer signs of recovery or growth.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD is below zero and negatively contracting, RSI is neutral at 34.117, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 4.359 and S2 at 4.187.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
0

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders. Analysts note undemanding valuation and healthy free cash flow, but improvements are expected to take time.

Neutral/Negative Catalysts

  • Analysts have lowered price targets recently, and technical indicators are bearish. No recent congress trading data or news to support a positive sentiment.

Financial Performance

In Q2 2026, revenue dropped by -5.88% YoY to $184.1M, net income fell by -200.80% YoY to -$6.91M, EPS declined by -218.18% YoY to -$0.13, and gross margin decreased by -11.29% YoY to 20.42%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have recently lowered price targets. TD Cowen reduced the target to $6.50 from $8 with a Hold rating, JPMorgan reduced it to $9 from $10 with a Neutral rating, and Guggenheim reduced it to $13 from $15 but maintains a Buy rating due to undemanding valuation and healthy free cash flow.

Wall Street analysts forecast DAVA stock price to rise
6 Analyst Rating
Wall Street analysts forecast DAVA stock price to rise
2 Buy
4 Hold
0 Sell
Moderate Buy
Current: 4.420
sliders
Low
8
Averages
10
High
15
Current: 4.420
sliders
Low
8
Averages
10
High
15
TD Cowen
Hold
downgrade
$8
AI Analysis
2026-02-23
Reason
TD Cowen
Price Target
$8
AI Analysis
2026-02-23
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Endava to $6.50 from $8 and keeps a Hold rating on the shares. The firm said they posted 2Q26 results largely aligned with plan and raised FY26 CC guide by about 1pt. 3Q26 outlook versus the Street weighed by FX/investments, but implied 4Q26 topped consensus by roughly 2%.
JPMorgan
Neutral
downgrade
$10 -> $9
2026-02-20
Reason
JPMorgan
Price Target
$10 -> $9
2026-02-20
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Endava to $9 from $10 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DAVA
Unlock Now

People Also Watch